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Abstract 
The Akt pathway is one of the most common molecular alterations in various human 
malignancies. However, its involvement in nasopharyngeal carcinoma (NPC) tumorigenesis 
has not been well established. In this study, the status of Akt activation and expression of its 
upstream and downstream molecules was investigated in 64 NPC and 38 non-malignant 
nasopharyngeal tissues by immunohistochemistry. The hotspot mutations of PIK3CA, 
encoding the p110alpha catalytic subunit of phosphatidylinositol 3-kinase (PI3K), were also 
determined in 25 of these NPC tissues. No hotspot mutations were found in any of the 
samples tested. Akt was activated in 27 (42.2%) and 23 (35.9%) NPCs, as indicated by p-Akt 
(Thr308) and p-Akt (Ser473) immunoreactivity, respectively. PTEN loss did not correlate 
statistically with activated Akt. However, a positive correlation was observed between 
activated Akt and phospho-epidermal growth factor receptor (p-EGFR), suggesting that the 
EGFR signaling might be one of the upstream regulators of the Akt pathway. The 
phosphorylation of forkhead (FKHR) and Bcl-2 associated death domain (BAD), but not 
mammalian target of rapamycin and glycogen synthase kinase-3beta, was significantly 
correlated with Akt activation. This implies that Akt promotes cell proliferation (as estimated 
by Ki-67) and survival, at least, through the inactivation of FKHR and BAD in NPC. Our 
data revealed that the EGFR/PI3K/Akt signaling pathway is important in NPC pathogenesis 
and that PIK3CA hotspot mutations are rare in NPC. 
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